These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 21742807

  • 41. Phospho-p70S6K/p85S6K and cdc2/cdk1 are novel targets for diffuse large B-cell lymphoma combination therapy.
    Zhao MY, Auerbach A, D'Costa AM, Rapoport AP, Burger AM, Sausville EA, Stass SA, Jiang F, Sands AM, Aguilera N, Zhao XF.
    Clin Cancer Res; 2009 Mar 01; 15(5):1708-20. PubMed ID: 19223503
    [Abstract] [Full Text] [Related]

  • 42. Specific role of phosphodiesterase 4B in lipopolysaccharide-induced signaling in mouse macrophages.
    Jin SL, Lan L, Zoudilova M, Conti M.
    J Immunol; 2005 Aug 01; 175(3):1523-31. PubMed ID: 16034090
    [Abstract] [Full Text] [Related]

  • 43. MiR155 sensitized B-lymphoma cells to anti-PD-L1 antibody via PD-1/PD-L1-mediated lymphoma cell interaction with CD8+T cells.
    Zheng Z, Sun R, Zhao HJ, Fu D, Zhong HJ, Weng XQ, Qu B, Zhao Y, Wang L, Zhao WL.
    Mol Cancer; 2019 Mar 30; 18(1):54. PubMed ID: 30925928
    [Abstract] [Full Text] [Related]

  • 44. Ferulic acid prevents LPS-induced up-regulation of PDE4B and stimulates the cAMP/CREB signaling pathway in PC12 cells.
    Huang H, Hong Q, Tan HL, Xiao CR, Gao Y.
    Acta Pharmacol Sin; 2016 Dec 30; 37(12):1543-1554. PubMed ID: 27665850
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. miR-21 modulates cisplatin resistance of gastric cancer cells by inhibiting autophagy via the PI3K/Akt/mTOR pathway.
    Gu Y, Fei Z, Zhu R.
    Anticancer Drugs; 2020 Apr 30; 31(4):385-393. PubMed ID: 31913198
    [Abstract] [Full Text] [Related]

  • 47. [Significance of mTOR (mammalian target of rapamycin) activity in human lymphomas].
    Márk Á.
    Magy Onkol; 2014 Jun 30; 58(2):143-8. PubMed ID: 25010764
    [Abstract] [Full Text] [Related]

  • 48. CD79B limits response of diffuse large B cell lymphoma to ibrutinib.
    Kim JH, Kim WS, Ryu K, Kim SJ, Park C.
    Leuk Lymphoma; 2016 Jun 30; 57(6):1413-22. PubMed ID: 26699656
    [Abstract] [Full Text] [Related]

  • 49. Concurrent inhibition of PI3-kinase and mTOR induces cell death in diffuse large B cell lymphomas, a mechanism involving down regulation of Mcl-1.
    Zang C, Eucker J, Liu H, Müller A, Possinger K, Scholz CW.
    Cancer Lett; 2013 Oct 10; 339(2):288-97. PubMed ID: 23200668
    [Abstract] [Full Text] [Related]

  • 50. Resistance to BTK inhibition by ibrutinib can be overcome by preventing FOXO3a nuclear export and PI3K/AKT activation in B-cell lymphoid malignancies.
    Kapoor I, Li Y, Sharma A, Zhu H, Bodo J, Xu W, Hsi ED, Hill BT, Almasan A.
    Cell Death Dis; 2019 Dec 04; 10(12):924. PubMed ID: 31801949
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Protein kinase A (PKA) isoform RIIbeta mediates the synergistic killing effect of cAMP and glucocorticoid in acute lymphoblastic leukemia cells.
    Ji Z, Mei FC, Miller AL, Thompson EB, Cheng X.
    J Biol Chem; 2008 Aug 08; 283(32):21920-5. PubMed ID: 18544528
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Targeting mTOR/p70S6K/glycolysis signaling pathway restores glucocorticoid sensitivity to 4E-BP1 null Burkitt Lymphoma.
    Gu L, Xie L, Zuo C, Ma Z, Zhang Y, Zhu Y, Gao J.
    BMC Cancer; 2015 Jul 20; 15():529. PubMed ID: 26189041
    [Abstract] [Full Text] [Related]

  • 58. Glycogen synthase kinase-3 plays a central role in mediating glucocorticoid-induced apoptosis.
    Spokoini R, Kfir-Erenfeld S, Yefenof E, Sionov RV.
    Mol Endocrinol; 2010 Jun 20; 24(6):1136-50. PubMed ID: 20371704
    [Abstract] [Full Text] [Related]

  • 59. Phosphodiesterase 4B is essential for T(H)2-cell function and development of airway hyperresponsiveness in allergic asthma.
    Jin SL, Goya S, Nakae S, Wang D, Bruss M, Hou C, Umetsu D, Conti M.
    J Allergy Clin Immunol; 2010 Dec 20; 126(6):1252-9.e12. PubMed ID: 21047676
    [Abstract] [Full Text] [Related]

  • 60. Phosphodiesterase 4B mediates extracellular signal-regulated kinase-dependent up-regulation of mucin MUC5AC protein by Streptococcus pneumoniae by inhibiting cAMP-protein kinase A-dependent MKP-1 phosphatase pathway.
    Lee J, Komatsu K, Lee BC, Lim JH, Jono H, Xu H, Kai H, Zhang ZJ, Yan C, Li JD.
    J Biol Chem; 2012 Jun 29; 287(27):22799-811. PubMed ID: 22610099
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.